| Typicality: | 0.364 |
| Saliency: | 0.268 |
| in 1994 | 2 | temporal |
| in europe | 2 | location |
| stent → be approved by → the fda | 4 |
| stent → be approved for → use | 4 |
| stent → be → approved | 3 |
| negative | neutral | positive |
| 0.086 | 0.766 | 0.148 |
| Raw frequency | 11 |
| Normalized frequency | 0.268 |
| Modifier score | 0.500 |
| Perplexity | 40.870 |